![Richard Wooster](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Wooster
Nessuna posizione attualmente
Profilo
Richard Wooster is an Independent Director at Ikena Oncology, Inc. and a Director at Illuminating Drug Discovery Ltd. He previously served as the Chief Scientific Officer at Translate Bio, Inc. from 2019 to 2021.
Prior to that, he was a Senior Investigator at Wellcome Trust Sanger Institute.
Richard also held the position of Vice President & Unit Head-Oncology at GlaxoSmithKline LLC from 2006 to 2013.
From 2013 to 2019, he served as the Chief Scientific Officer & President-R&D at Tarveda Therapeutics, Inc. Dr. Wooster obtained his undergraduate and doctorate degrees from the University Of Dundee.
Posizioni attive di Richard Wooster
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Richard Wooster
| Società | Posizione | Fine |
|---|---|---|
| TRANSLATE BIO, INC. | Direttore Tecnico/Scientifico/R&S | 14/09/2021 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Presidente | 01/03/2015 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | 01/01/2013 |
| IMAGENEBIO, INC. | Direttore/Membro del Consiglio | - |
Wellcome Trust Sanger Institute
 Wellcome Trust Sanger Institute BiotechnologyHealth Technology Provides genomic research services | Corporate Officer/Principal | - |
Formazione di Richard Wooster
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
33
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Provides genomic research services | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
Ikena Oncology, Inc.
 Ikena Oncology, Inc. BiotechnologyHealth Technology Develops metabolic enzymes based immunotherapy for oncology applications | Health Technology |
